GBT - Global Blood Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $26.89. This is a potential upside of $26.89 (0%) from yesterday's end of day stock price of $0.

Global Blood Therapeutics's activity chart (see below) currently has 185 price targets and 105 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.07% with an average time for these price targets to be met of 333.64 days.

Most recent stock forecast was given by GREGORY RENZA from RBC on 09-Aug-2022. First documented stock forecast 08-Sep-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$68.5

$0.01 (0.01%)

$64

2 years 3 months 14 days ago
(09-Aug-2022)

1/3 (33.33%)

$1.91 (2.87%)

276

Hold

$68.5

$0.01 (0.01%)

2 years 3 months 14 days ago
(09-Aug-2022)

3/4 (75%)

$1.91 (2.87%)

313

Hold

$68.5

$0.01 (0.01%)

$67

2 years 3 months 14 days ago
(09-Aug-2022)

7/9 (77.78%)

$1.91 (2.87%)

825

Hold

$68.5

$0.01 (0.01%)

$133

2 years 3 months 14 days ago
(09-Aug-2022)

1/5 (20%)

$1.91 (2.87%)

567

Hold

$71

2 years 3 months 15 days ago
(08-Aug-2022)

0/1 (0%)

$35.72 (101.25%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GBT (Global Blood Therapeutics) average time for price targets to be met?

On average it took 333.64 days on average for the stock forecasts to be realized with a an average price target met ratio 53.07

Which analyst has the current highest performing score on GBT (Global Blood Therapeutics) with a proven track record?

RITU BARAL

Which analyst has the most public recommendations on GBT (Global Blood Therapeutics)?

Ritu Baral works at TD COWEN and has 0 price targets and 0 ratings on GBT

Which analyst is the currently most bullish on GBT (Global Blood Therapeutics)?

Liana Moussatos with highest potential upside - $83.51

Which analyst is the currently most reserved on GBT (Global Blood Therapeutics)?

Tessa Romero with lowest potential downside - -$32.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?